Launch VideoHomepage >>>
Big private equity firms are working to make their products more accessible to non-accredited investors, with 401(k) plans seen as the holy grail. Here, we explore the stumbling blocks and potential solutions. Click the image below to open. Please note this is a sample report – access to the full report is for subscribers only. Call us on +1 212 [...]
Rotech Healthcare Inc., a provider of home respiratory products, filed for bankruptcy saying its plan to cut debt by about half and reorganize is supported by a majority of its noteholders. Click here to continue reading. _____________________________________________________________ Bloomberg Brief Bankruptcy & Restructuring To take a risk free 30 day trial click here. Ready to subscribe? Save 35% today off [...]
Kansas, which dedicated casino proceeds to pension relief last year, is considering another gamble as lawmakers debate borrowing $1.5 billion to bolster the nation’s 11th-weakest state retirement plan. Click here to continue reading.
What we’ve got on our front page this week: Fees on U.S. structured notes tied to equities are at a three-year high. Inside we’ve got more on fees (a table and a few charts), after doing an analysis of all the fee-paying U.S. notes since January 2010. Also in this issue: China moves closer to [...]
Crisis Watch by David Powell, Bloomberg Economist Comparisons between the dangers posed by the banking systems of Cyprus and Malta appear to be misplaced, though the rapid expansion of the Maltese financial sector has the potential to someday become a problem. Click here to read the full article.
U.K. banks including Royal Bank of Scotland Group Plc and Lloyds Banking Group Plc may avoid the need to sell new shares to bolster their balance sheets after the Bank of England used more lenient rules than those advocated by European regulators. Click here to continue reading.
By Asthika Goonewardene, Pharmaceuticals Equity Research Analyst, Bloomberg Industries The cost of allegations that process patents may have been infringed under a biosimilar application may deter small generic developers from pursuing approval through the 351(k) pathway, which was specifically set up for copies of cheaper biologic drugs. The FDA created an abbreviated pathway for generic [...]
The U.S. Senate Permanent Subcommittee report on JPMorgan Chase & Co.’s London Whale trade may have given new life to a controversial provision of the Dodd-Frank Act, known as the swap push-out rule. Click here to continue reading.
MetLife Inc., the insurer that benefited from hedging against interest rate declines in the last two years, has started buying derivative protection against higher interest rates. “Now that rates are extremely low, we’ve taken the opposite tack,” MetLife Chief Executive Officer Steve Kandarian said on a Feb. 15 call with analysts. “We’re buying out of the money hedges to protect against significantly [...]
The European Central Bank’s threat to cut off Cyprus’s access to the Emergency Lending Facility (ELA) on Monday will be the main focus of investors early next week. Cypriot lawmakers begin debate today on legislation to unlock bailout funds and prevent a financial collapse. The Cyprus bank holiday is scheduled to expire on Tuesday and a failure to reach terms [...]
